Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly Recall
Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly
FDA recall Class II
Ongoing
FDA lists this Class II recall for Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0197-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 31, 2026
- FDA report date
- Oct 28, 2026
- Quantity in commerce
- 3746 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly
Affected model & UDI checker
Search the exact identifiers published for Z-0197-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 9733068 | Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly | Check source notice | Not specified |
FDA code information
UDI: 00643169702943/ Lots: 066500526 066501226 066503326 066504726 066506326 066509826; UDI:00643169030121/Lots: 066500526 066506326
Why was this product recalled?
Sterile Passive spheres and biopsy needle kits contain variation in the reflective material which may affect the ability of the navigation system to detect and track the spheres.
What actions did Medtronic Navigation, Inc. take?
On September 11, 2026 Medtronic Navigation Inc. issued a Urgent Medical Device Recall notification email. Medtronic ask consignees to take the following actions: 1. Immediately locate and quarantine all unused impacted product(s).; 2. Return unused impacted product(s) to Medtronic following the instructions in the enclosed Customer Confirmation Form.; 3. Complete the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information, and email the completed form to Medtronic at neuro.quality@medtronic.com.; 4. If the affected devices have already been utilized and/or discarded, we still ask that you complete and return the Customer Confirmation Form detailing that information.; 5. This notice needs to be passed on to all those who need to be aware within your organization or to any organization where the potentially affected devices have been transferred. Please maintain a copy of this notice in your records.; 6. If you purchase this product directly from NDI, please contact NDI for the list of impacted product and instructions for return: spheres-na@ndigital.com
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0197-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology